Fierce Pharma13h
South Africa's Aspen hit with warning letter chiding the continent's largest drugmaker over sterility issues
After rising to prominence during the COVID-19 pandemic, South African drugmaker Aspen Pharmacare has landed in the FDA's ...
Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq
Combination, if successful, would create a new publicly-listed eye care company combining Betaliq’s EyeSol® water-free drug delivery technology ...
Eyenovia, Inc.: Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq
Combination, if successful, would create a new publicly-listed eye care company combining Betaliq's EyeSol® water-free drug delivery technology for glaucoma with Eyenovia's Optejet® device platform Th ...
Living Space: 9 things you should definitely declutter before spring
If you plan to polish your home from top to bottom soon, take a few minutes now to declutter your cleaning supplies so you’ll ...
Managed Healthcare Executive7h
FDA Approves First-Ever Cell Therapy Treatment for Rare Progressive Eye Disease
Encelto is small, semi-permeable capsule implanted in the eye that contains allogeneic retinal pigment epithelium cells ...
Eyenovia enters non-binding LOI to effect reverse merger with Betaliq
Eyenovia (EYEN), has entered into a non-binding letter of intent contemplating a potential reverse merger transaction with Betaliq, a clinical ...